Last 12 months
Inside the activity.
0 purchase rows · 59 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 9 |
| Jan 2026 | 0 | 4 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 26 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 6 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 14 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 04, 2025 Filed Dec 8, 2025 21:06 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
GiftCommon Stock | 51,885 | $0.00 | $0.00 |
DisclosureSEC source: 0001827672-25-000005 · wk-form4_1765227987.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,750 F1 · ownership.direct: The Reporting Person transferred 51,885 shares of common stock to the Bobak Azamian Living Trust for no consideration. The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| September 24, 2025 Filed Sep 26, 2025 20:08 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 6,000 | $55.37 | $332,220.00 |
DisclosureSEC source: 0001827672-25-000003 · wk-form4_1758917331.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Plan reported Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 812,106 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $55.19 to $55.93. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| September 16, 2025 Filed Sep 18, 2025 21:00 UTC |
LINK WILLIAM J PHDDirector
|
GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001228684-25-000003 · wk-form4_1758229231.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,332 Read SEC document |
| September 15, 2025 Filed Sep 16, 2025 20:06 UTC |
Morrison Scott WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 1,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001662426-25-000005 · wk-form4_1758053184.xml · derivative · entry 3 Morrison Scott W · CIK 0001662426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,334 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: The RSUs vested in three equal annual installments on September 15th of 2023, 2024, and 2025, subject to the Reporting Person's continuous service. F3 · derivative.expiration_date: The RSUs vested in three equal annual installments on September 15th of 2023, 2024, and 2025, subject to the Reporting Person's continuous service. Read SEC document |
| September 15, 2025 Filed Sep 16, 2025 20:06 UTC |
Morrison Scott WDirector
|
Exercise / conversionCommon Stock | 1,334 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001662426-25-000005 · wk-form4_1758053184.xml · nonDerivative · entry 1 Morrison Scott W · CIK 0001662426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,684 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| September 08, 2025 Filed Sep 10, 2025 21:03 UTC |
LINK WILLIAM J PHDDirector
|
SaleCommon Stock | 27,116 | $57.00 | $1,545,612.00 |
DisclosureSEC source: 0001819790-25-000113 · wk-form4_1757538213.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,332 F1 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $56.66 to $57.45. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 11, 2025 Filed Aug 13, 2025 20:32 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 6,000 | $50.00 | $300,000.00 |
DisclosureSEC source: 0001819790-25-000110 · wk-form4_1755117154.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: Plan reported Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 818,106 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024. F2 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 20:07 UTC |
Farrow Jeffrey SSee Remarks
|
SaleCommon Stock | 13,608 | $40.42 | $550,035.36 |
DisclosureSEC source: 0001819790-25-000102 · wk-form4_1750277272.xml · nonDerivative · entry 2 Farrow Jeffrey S · CIK 0001405253 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,704 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| June 16, 2025 Filed Jun 17, 2025 20:07 UTC |
Lin Elizabeth YeuChief Medical Officer
|
SaleCommon Stock | 1,006 | $41.08 | $41,326.48 |
DisclosureSEC source: 0001819790-25-000097 · wk-form4_1750190816.xml · nonDerivative · entry 2 Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,694 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:07 UTC |
Farrow Jeffrey SSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 27,881 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000102 · wk-form4_1750277272.xml · derivative · entry 3 Farrow Jeffrey S · CIK 0001405253 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,763 Underlying: Common Stock · 27,881 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted on April 24, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service. F4 · derivative.expiration_date: RSUs granted on April 24, 2023, under the Tarsus Pharmaceuticals, Inc. 2020 Stock Plan. 25% of the RSUs will vest on June 15th of each of 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service. Read SEC document |
| June 16, 2025 Filed Jun 18, 2025 20:07 UTC |
Farrow Jeffrey SSee Remarks
|
Exercise / conversionCommon Stock | 27,881 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001819790-25-000102 · wk-form4_1750277272.xml · nonDerivative · entry 1 Farrow Jeffrey S · CIK 0001405253 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,312 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:05 UTC |
CHAUDHURI BHASKARDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000094 · wk-form4_1750104325.xml · derivative · entry 4 CHAUDHURI BHASKAR · CIK 0001458643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F5 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F5 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:05 UTC |
CHAUDHURI BHASKARDirector
|
Exercise / conversionCommon Stock | 3,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001819790-25-000094 · wk-form4_1750104325.xml · nonDerivative · entry 1 CHAUDHURI BHASKAR · CIK 0001458643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:04 UTC |
Goldberg Andrew D.Director
|
Exercise / conversionRestricted Stock Units · Derivative | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000092 · wk-form4_1750104285.xml · derivative · entry 4 Goldberg Andrew D. · CIK 0001827722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F5 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F5 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:04 UTC |
Goldberg Andrew D.Director
|
Exercise / conversionCommon Stock | 3,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001819790-25-000092 · wk-form4_1750104285.xml · nonDerivative · entry 1 Goldberg Andrew D. · CIK 0001827722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:04 UTC |
YARNO WENDY LDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000091 · wk-form4_1750104266.xml · derivative · entry 4 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F5 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F5 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:04 UTC |
YARNO WENDY LDirector
|
Exercise / conversionCommon Stock | 3,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001819790-25-000091 · wk-form4_1750104266.xml · nonDerivative · entry 1 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:04 UTC |
Morrison Scott WDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000090 · wk-form4_1750104245.xml · derivative · entry 5 Morrison Scott W · CIK 0001662426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F5 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F5 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:04 UTC |
Morrison Scott WDirector
|
Exercise / conversionCommon Stock | 3,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001819790-25-000090 · wk-form4_1750104245.xml · nonDerivative · entry 1 Morrison Scott W · CIK 0001662426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,350 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:03 UTC |
LINK WILLIAM J PHDDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000088 · wk-form4_1750104194.xml · derivative · entry 5 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F6 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F6 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 20:03 UTC |
LINK WILLIAM J PHDDirector
|
Exercise / conversionCommon Stock | 3,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001819790-25-000088 · wk-form4_1750104194.xml · nonDerivative · entry 1 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,448 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:07 UTC |
Lin Elizabeth YeuChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000097 · wk-form4_1750190816.xml · derivative · entry 5 Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,350 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F4 · derivative.expiration_date: RSUs granted on June 13, 2024, in connection with the Reporting Person's service as a non-employee director as of the Company's 2024 annual meeting of stockholders. The RSUs will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:07 UTC |
Lin Elizabeth YeuChief Medical Officer
|
Exercise / conversionCommon Stock | 3,350 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001819790-25-000097 · wk-form4_1750190816.xml · nonDerivative · entry 1 Lin Elizabeth Yeu · CIK 0001842190 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. F1 · price: The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:05 UTC |
Goodrich KatherineDirector
|
GrantRestricted Stock Units · Derivative | 2,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000093 · wk-form4_1750104304.xml · derivative · entry 2 Goodrich Katherine · CIK 0002044770 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,954 Underlying: Common Stock · 2,954 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Company's common stock. F3 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F3 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:05 UTC |
Goodrich KatherineDirector
|
GrantStock Option (right to buy) · Derivative | 4,540 | $0.00 Strike: $40.95 | $0.00 |
DisclosureSEC source: 0001819790-25-000093 · wk-form4_1750104304.xml · derivative · entry 1 Goodrich Katherine · CIK 0002044770 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,540 Underlying: Common Stock · 4,540 shares Expires 2035-06-11 F1 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:05 UTC |
CHAUDHURI BHASKARDirector
|
GrantRestricted Stock Units · Derivative | 2,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000094 · wk-form4_1750104325.xml · derivative · entry 3 CHAUDHURI BHASKAR · CIK 0001458643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,954 Underlying: Common Stock · 2,954 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:05 UTC |
CHAUDHURI BHASKARDirector
|
GrantStock Option (right to buy) · Derivative | 4,540 | $0.00 Strike: $40.95 | $0.00 |
DisclosureSEC source: 0001819790-25-000094 · wk-form4_1750104325.xml · derivative · entry 2 CHAUDHURI BHASKAR · CIK 0001458643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,540 Underlying: Common Stock · 4,540 shares Expires 2035-06-11 F2 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:04 UTC |
Goldberg Andrew D.Director
|
GrantRestricted Stock Units · Derivative | 2,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000092 · wk-form4_1750104285.xml · derivative · entry 3 Goldberg Andrew D. · CIK 0001827722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,954 Underlying: Common Stock · 2,954 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:04 UTC |
Goldberg Andrew D.Director
|
GrantStock Option (right to buy) · Derivative | 4,540 | $0.00 Strike: $40.95 | $0.00 |
DisclosureSEC source: 0001819790-25-000092 · wk-form4_1750104285.xml · derivative · entry 2 Goldberg Andrew D. · CIK 0001827722 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,540 Underlying: Common Stock · 4,540 shares Expires 2035-06-11 F2 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:04 UTC |
YARNO WENDY LDirector
|
GrantRestricted Stock Units · Derivative | 2,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000091 · wk-form4_1750104266.xml · derivative · entry 3 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,954 Underlying: Common Stock · 2,954 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:04 UTC |
YARNO WENDY LDirector
|
GrantStock Option (right to buy) · Derivative | 4,540 | $0.00 Strike: $40.95 | $0.00 |
DisclosureSEC source: 0001819790-25-000091 · wk-form4_1750104266.xml · derivative · entry 2 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,540 Underlying: Common Stock · 4,540 shares Expires 2035-06-11 F2 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:04 UTC |
Morrison Scott WDirector
|
GrantRestricted Stock Units · Derivative | 2,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000090 · wk-form4_1750104245.xml · derivative · entry 4 Morrison Scott W · CIK 0001662426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,954 Underlying: Common Stock · 2,954 shares Expires not disclosed F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F4 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F4 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:04 UTC |
Morrison Scott WDirector
|
GrantStock Option (right to buy) · Derivative | 4,540 | $0.00 Strike: $40.95 | $0.00 |
DisclosureSEC source: 0001819790-25-000090 · wk-form4_1750104245.xml · derivative · entry 3 Morrison Scott W · CIK 0001662426 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,540 Underlying: Common Stock · 4,540 shares Expires 2035-06-11 F2 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:03 UTC |
LINK WILLIAM J PHDDirector
|
GrantRestricted Stock Units · Derivative | 2,954 | $0.00 | $0.00 |
DisclosureSEC source: 0001819790-25-000088 · wk-form4_1750104194.xml · derivative · entry 4 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,954 Underlying: Common Stock · 2,954 shares Expires not disclosed F4 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock. F5 · derivative.exercise_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. F5 · derivative.expiration_date: RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 20:03 UTC |
LINK WILLIAM J PHDDirector
|
GrantStock Option (right to buy) · Derivative | 4,540 | $0.00 Strike: $40.95 | $0.00 |
DisclosureSEC source: 0001819790-25-000088 · wk-form4_1750104194.xml · derivative · entry 3 LINK WILLIAM J PHD · CIK 0001228684 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,540 Underlying: Common Stock · 4,540 shares Expires 2035-06-11 F3 · derivative.exercise_date: Annual option granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2025 annual meeting of stockholders. The option will vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. Read SEC document |
| June 09, 2025 Filed Jun 11, 2025 20:50 UTC |
Mottiwala AzizChief Commercial Officer
|
SaleCommon Stock | 17,500 | $43.76 | $765,800.00 |
DisclosureSEC source: 0001819790-25-000081 · wk-form4_1749675042.xml · nonDerivative · entry 1 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,557 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 10, 2025. F2 · price: The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $43.42 to $44.55. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 20:47 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 6,000 | $50.00 | $300,000.00 |
DisclosureSEC source: 0001819790-25-000061 · wk-form4_1743022033.xml · nonDerivative · entry 1 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: No plan indicated Ownership: Indirect · By the Bobak Azamian Living Trust established April 16, 2018 Disclosed balance after: 824,106 F1 · kind: The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2024. F2 · ownership.nature: The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 01:49 UTC |
Mottiwala AzizChief Commercial Officer
|
SaleCommon Stock | 3,365 | $50.11 | $168,620.15 |
DisclosureSEC source: 0001819790-25-000059 · wk-form4_1742521788.xml · nonDerivative · entry 3 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,057 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 01:49 UTC |
Wahl BryanGeneral Counsel
|
SaleCommon Stock | 3,084 | $50.11 | $154,539.24 |
DisclosureSEC source: 0001819790-25-000057 · wk-form4_1742521746.xml · nonDerivative · entry 3 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,712 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 01:49 UTC |
Neervannan SeshadriChief Operating Officer
|
SaleCommon Stock | 2,435 | $50.11 | $122,017.85 |
DisclosureSEC source: 0001819790-25-000058 · wk-form4_1742521768.xml · nonDerivative · entry 3 Neervannan Seshadri · CIK 0001827584 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,682 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 01:48 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 8,534 | $50.11 | $427,638.74 |
DisclosureSEC source: 0001819790-25-000055 · wk-form4_1742521708.xml · nonDerivative · entry 3 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,635 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 01:48 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
SaleCommon Stock | 2,137 | $50.11 | $107,085.07 |
DisclosureSEC source: 0001819790-25-000056 · wk-form4_1742521727.xml · nonDerivative · entry 3 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,355 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 01:48 UTC |
Farrow Jeffrey SSee Remarks
|
SaleCommon Stock | 1,186 | $50.11 | $59,430.46 |
DisclosureSEC source: 0001819790-25-000054 · wk-form4_1742521688.xml · nonDerivative · entry 3 Farrow Jeffrey S · CIK 0001405253 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,431 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:49 UTC |
Mottiwala AzizChief Commercial Officer
|
SaleCommon Stock | 3,557 | $47.40 | $168,601.80 |
DisclosureSEC source: 0001819790-25-000059 · wk-form4_1742521788.xml · nonDerivative · entry 2 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,422 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:49 UTC |
Wahl BryanGeneral Counsel
|
SaleCommon Stock | 3,261 | $47.40 | $154,571.40 |
DisclosureSEC source: 0001819790-25-000057 · wk-form4_1742521746.xml · nonDerivative · entry 2 Wahl Bryan · CIK 0001841401 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,796 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:49 UTC |
Neervannan SeshadriChief Operating Officer
|
SaleCommon Stock | 2,543 | $47.40 | $120,538.20 |
DisclosureSEC source: 0001819790-25-000058 · wk-form4_1742521768.xml · nonDerivative · entry 2 Neervannan Seshadri · CIK 0001827584 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,117 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:48 UTC |
Azamian Bobak R.Director · President/CEO and Board Chair
|
SaleCommon Stock | 8,551 | $47.40 | $405,317.40 |
DisclosureSEC source: 0001819790-25-000055 · wk-form4_1742521708.xml · nonDerivative · entry 2 Azamian Bobak R. · CIK 0001827672 · Director · President/CEO and Board Chair 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,169 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:48 UTC |
Whitfield Dianne C.Chief Human Resources Officer
|
SaleCommon Stock | 2,259 | $47.40 | $107,076.60 |
DisclosureSEC source: 0001819790-25-000056 · wk-form4_1742521727.xml · nonDerivative · entry 2 Whitfield Dianne C. · CIK 0001839516 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,492 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 19, 2025 Filed Mar 21, 2025 01:48 UTC |
Farrow Jeffrey SSee Remarks
|
SaleCommon Stock | 1,254 | $47.40 | $59,439.60 |
DisclosureSEC source: 0001819790-25-000054 · wk-form4_1742521688.xml · nonDerivative · entry 2 Farrow Jeffrey S · CIK 0001405253 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,617 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| March 18, 2025 Filed Mar 21, 2025 01:49 UTC |
Mottiwala AzizChief Commercial Officer
|
SaleCommon Stock | 3,643 | $46.29 | $168,634.47 |
DisclosureSEC source: 0001819790-25-000059 · wk-form4_1742521788.xml · nonDerivative · entry 1 Mottiwala Aziz · CIK 0001788542 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,979 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.